{"schema_version":"1.0","type":"article","title":"Anthropic上市想做藥，最後還是賣給藥廠","url":"https://drugnews.com.tw/articles/2026-11-01-anthropic-ipo-ai-drug-lab.html","markdown_url":"https://drugnews.com.tw/articles/2026-11-01-anthropic-ipo-ai-drug-lab.md","lang":"zh-Hant","date":"2026-11-01","publish_at":"2026-11-01T08:00:00+08:00","updated_at":"2026-11-01","category":"商業分析系列","topic":"商業分析系列","tags":["Anthropic","AI製藥","IPO","諾和諾德","CDMO"],"summary":"Anthropic 10/26 公開 S-1，上半年營收 162.86 億美元，並把濕實驗室、Coefficient Bio 與自有藥物計畫寫進成長故事。它暫不做人體試驗，前十大藥廠九家是客戶；最可能的出路是把候選分子授權給藥廠，而不是自己做到上市。","key_points":["Anthropic 10 月 28 日宣布買下只有一名員工的 Mithril Medicine；創辦人用 Claude 協調 11 家外部實驗室，不到 18 個月把一種罕見肌肉疾病的候選抗體做到小鼠數據。","Anthropic 2026 年 10 月 26 日公開的 S-1 顯示，上半年營收 162.86 億美元，807.48 億美元淨損中有 723.88 億美元是非現金公允價值變動，營業虧損 6.93 億美元。","截至 2026 年 9 月 30 日，財星 500 大前十大藥廠有九家是 Anthropic 客戶；諾和諾德 2026 年 4 月與 OpenAI、9 月與 Anthropic 先後簽約，藥廠用分散供應商回應資料外洩疑慮。"],"facts":[{"claim":"Anthropic 2026 上半年營收","value":16286,"unit":"百萬美元","as_of":"2026-06-30","source":"https://www.sec.gov/Archives/edgar/data/0002130357/000162828026067168/anthropicpbc-sx1.htm"},{"claim":"Anthropic 2025 上半年營收","value":1163,"unit":"百萬美元","as_of":"2025-06-30","source":"https://www.sec.gov/Archives/edgar/data/0002130357/000162828026067168/anthropicpbc-sx1.htm"},{"claim":"Anthropic 2026 上半年淨損","value":80748,"unit":"百萬美元","as_of":"2026-06-30","source":"https://www.sec.gov/Archives/edgar/data/0002130357/000162828026067168/anthropicpbc-sx1.htm"},{"claim":"Anthropic 2026 上半年可轉債、衍生負債與 SAFE 公允價值變動損失（非現金）","value":72388,"unit":"百萬美元","as_of":"2026-06-30","source":"https://www.sec.gov/Archives/edgar/data/0002130357/000162828026067168/anthropicpbc-sx1.htm"},{"claim":"Anthropic 2026 上半年營業虧損","value":693,"unit":"百萬美元","as_of":"2026-06-30","source":"https://www.sec.gov/Archives/edgar/data/0002130357/000162828026067168/anthropicpbc-sx1.htm"},{"claim":"Anthropic 2025 上半年營業虧損","value":2135,"unit":"百萬美元","as_of":"2025-06-30","source":"https://www.sec.gov/Archives/edgar/data/0002130357/000162828026067168/anthropicpbc-sx1.htm"},{"claim":"Anthropic 2026 第二季營業利益","value":974,"unit":"百萬美元","as_of":"2026-06-30","source":"https://finance.yahoo.com/technology/live/anthropic-ipo-live-updates-frontier-ai-lab-discloses-revenue-and-risks-in-highly-anticipated-s-1-filing-141702607.html"},{"claim":"Anthropic S-1 公開日與 Nasdaq 代號","value":"2026-10-26／ANT","unit":"","as_of":"2026-10-26","source":"https://www.sec.gov/Archives/edgar/data/0002130357/000162828026067168/anthropicpbc-sx1.htm"},{"claim":"財星 500 大前十大藥廠中為 Anthropic 客戶的家數","value":9,"unit":"家","as_of":"2026-09-30","source":"https://www.beckershospitalreview.com/healthcare-information-technology/ai/anthropic-ipo-filing-flags-healthcare-drug-discovery-as-growth-bets/"},{"claim":"過去 12 個月貢獻至少 10 萬美元營收的 Anthropic 客戶數","value":11900,"unit":"家以上","as_of":"2026-09-30","source":"https://www.beckershospitalreview.com/healthcare-information-technology/ai/anthropic-ipo-filing-flags-healthcare-drug-discovery-as-growth-bets/"},{"claim":"Coefficient Bio 收購對價（媒體報導，股票）","value":400,"unit":"百萬美元","as_of":"2026-09-18","source":"https://ca.finance.yahoo.com/news/exclusive-anthropic-quietly-sets-biology-100255331.html"},{"claim":"Claude Science 發表日","value":"2026-06-30","unit":"","as_of":"2026-06-30","source":"https://technews.tw/2026/07/08/anthropic-launches-claude-science-for-in-house-ai-drug-discovery/"},{"claim":"Claude Science 內建科學技能、連接器與資料庫數","value":60,"unit":"個以上","as_of":"2026-07-08","source":"https://technews.tw/2026/07/08/anthropic-launches-claude-science-for-in-house-ai-drug-discovery/"},{"claim":"ART 酵素系統搜尋使用的 Claude 代理數","value":950,"unit":"個（約）","as_of":"2026-09-23","source":"https://forklog.com/en/news/claude-ai-helps-uncover-new-enzyme-system-in-bacteriophage-dna"},{"claim":"ART 酵素系統搜尋耗時","value":21,"unit":"小時","as_of":"2026-09-23","source":"https://forklog.com/en/news/claude-ai-helps-uncover-new-enzyme-system-in-bacteriophage-dna"},{"claim":"ART 搜尋篩選的反轉錄酶數","value":200000,"unit":"個以上","as_of":"2026-09-23","source":"https://forklog.com/en/news/claude-ai-helps-uncover-new-enzyme-system-in-bacteriophage-dna"},{"claim":"ART 搜尋初步候選系統數","value":3500,"unit":"個（約）","as_of":"2026-09-23","source":"https://forklog.com/en/news/claude-ai-helps-uncover-new-enzyme-system-in-bacteriophage-dna"},{"claim":"Narasimhan 估計 AI 平台可把研發到核准時間縮短到","value":"7–8","unit":"年（原約 12 年）","as_of":"2026-07-08","source":"https://technews.tw/2026/07/08/anthropic-launches-claude-science-for-in-house-ai-drug-discovery/"},{"claim":"Narasimhan 估計產業成功率可提高到","value":16,"unit":"%（原約 8%）","as_of":"2026-07-08","source":"https://technews.tw/2026/07/08/anthropic-launches-claude-science-for-in-house-ai-drug-discovery/"},{"claim":"諾和諾德與 Anthropic 宣布合作日","value":"2026-09-16","unit":"","as_of":"2026-09-16","source":"https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=916768"},{"claim":"諾和諾德與 OpenAI 宣布合作日","value":"2026-04-14","unit":"","as_of":"2026-04-14","source":"https://www.fiercepharma.com/pharma/novo-taps-openai-deploy-ai-across-rd-manufacturing-and-corporate-functions"},{"claim":"OpenAI 宣布收購 Orchestra Bio 日","value":"2026-10-20","unit":"","as_of":"2026-10-20","source":"https://unite.ai/openai-acquires-orchestra-bio-to-expand-rosalind-life-sciences-tools"},{"claim":"Isomorphic Labs 2026 年 5 月募資金額","value":2100,"unit":"百萬美元","as_of":"2026-05-12","source":"https://whtc.com/2026/05/12/google-backed-isomorphic-raises-2-1-billion-to-scale-ai-driven-drug-discovery/"},{"claim":"博弘雲端成為 Anthropic 台灣經銷夥伴日","value":"2026-01-23","unit":"","as_of":"2026-01-23","source":"https://wantrich.chinatimes.com/news/20260123900310-420101"},{"claim":"台康生技擴充雙特異抗體等生物藥 CDMO 能力（BIO 2026）","value":"2026-06-30","unit":"","as_of":"2026-06-30","source":"https://geneonline.news/bio2026-eirgenix-026newsjune/"}],"sections":["01｜「不和藥廠競爭」，只說對了一半","02｜一個人的藥廠，被 Anthropic 買下","03｜招股書裡，能收錢的只有一本帳","04｜藥廠的對策：兩家都簽","05｜台灣接得到哪一段","06｜它要的是談判桌上的座位","參考資料"],"references":[{"title":"Anthropic, PBC Form S-1","source":"U.S. SEC","date":"2026-10-26","url":"https://www.sec.gov/Archives/edgar/data/0002130357/000162828026067168/anthropicpbc-sx1.htm"},{"title":"Exclusive: Anthropic quietly sets up biology lab as it ramps AI drug program","source":"Reuters（Yahoo Finance 轉載","date":"2026-09-18","url":"https://ca.finance.yahoo.com/news/exclusive-anthropic-quietly-sets-biology-100255331.html"},{"title":"Anthropic IPO filing flags healthcare, drug discovery as growth bets","source":"Becker's Hospital Review","date":"2026-10-26","url":"https://www.beckershospitalreview.com/healthcare-information-technology/ai/anthropic-ipo-filing-flags-healthcare-drug-discovery-as-growth-bets/"},{"title":"Anthropic IPO live updates: S-1 filing discloses $16.3B in first-half revenue","source":"Yahoo Finance","date":"2026-10-26","url":"https://finance.yahoo.com/technology/live/anthropic-ipo-live-updates-frontier-ai-lab-discloses-revenue-and-risks-in-highly-anticipated-s-1-filing-141702607.html"},{"title":"What Anthropic's S-1 Reveals About Its Plans For Scientific Research","source":"Forbes","date":"2026-10-26","url":"https://www.forbes.com/sites/alexknapp/2026/10/26/anthropics-s-1-promises-new-scientific-discoveries-and-new-threats/"},{"title":"Anthropic launches Claude Science for in-house AI drug discovery","source":"TechNews 科技新報","date":"2026-07-08","url":"https://technews.tw/2026/07/08/anthropic-launches-claude-science-for-in-house-ai-drug-discovery/"},{"title":"Claude AI helps uncover new enzyme system in bacteriophage DNA","source":"ForkLog","date":"2026-09-24","url":"https://forklog.com/en/news/claude-ai-helps-uncover-new-enzyme-system-in-bacteriophage-dna"},{"title":"Anthropic is operating a lab that conducts biology experiments","source":"TechCrunch","date":"2026-09-18","url":"https://techcrunch.com/2026/09/18/anthropic-is-operating-a-lab-that-conducts-biology-experiments/"},{"title":"Novo Nordisk and Anthropic collaborate on drug discovery","source":"Novo Nordisk","date":"2026-09-16","url":"https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=916768"},{"title":"Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions","source":"Fierce Pharma","date":"2026-04-14","url":"https://www.fiercepharma.com/pharma/novo-taps-openai-deploy-ai-across-rd-manufacturing-and-corporate-functions"},{"title":"OpenAI acquires Orchestra Bio to expand Rosalind life sciences tools","source":"Unite.AI","date":"2026-10-20","url":"https://unite.ai/openai-acquires-orchestra-bio-to-expand-rosalind-life-sciences-tools"},{"title":"Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery","source":"Reuters（WHTC 轉載","date":"2026-05-12","url":"https://whtc.com/2026/05/12/google-backed-isomorphic-raises-2-1-billion-to-scale-ai-driven-drug-discovery/"},{"title":"博弘雲端成為 Anthropic 台灣經銷合作夥伴","source":"工商時報","date":"2026-01-23","url":"https://wantrich.chinatimes.com/news/20260123900310-420101"},{"title":"EirGenix at BIO 2026: CDMO and biosimilar dual track","source":"GeneOnline","date":"2026-06-30","url":"https://geneonline.news/bio2026-eirgenix-026newsjune/"},{"title":"Anthropic buys a one-person biotech and starts its own drug programmes","source":"The Next Web","date":"2026-10-28","url":"https://thenextweb.com/news/anthropic-mithril-acquisition-claude-drug-development"}],"images":[{"alt":"圖1｜Anthropic 半年內補齊做藥零件","url":"https://drugnews.com.tw/assets/articles/anthropic-ipo-ai-drug-lab/figure-01.png"},{"alt":"圖2｜營收放大 14 倍，淨損九成是帳面數字","url":"https://drugnews.com.tw/assets/articles/anthropic-ipo-ai-drug-lab/figure-02.png"},{"alt":"圖3｜三種 AI 做藥模式","url":"https://drugnews.com.tw/assets/articles/anthropic-ipo-ai-drug-lab/figure-03.png"},{"alt":"圖4｜模型公司做到候選分子，後面交給藥廠","url":"https://drugnews.com.tw/assets/articles/anthropic-ipo-ai-drug-lab/figure-04.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/anthropic-ipo-ai-drug-lab/cover.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-11-01）。Anthropic上市想做藥，最後還是賣給藥廠。https://drugnews.com.tw/articles/2026-11-01-anthropic-ipo-ai-drug-lab.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{},"fb_body":"全球前十大藥廠有九家在用 Claude。它的開發商 Anthropic 10 月 26 日公開上市申請書，卻把自己的濕實驗室、媒體報導以約 4 億美元股票買下的 Coefficient Bio、自有藥物計畫，全寫進成長故事。\n\n藥廠的疑問很直接：研發資料交給它，會不會養出對手？\n\n招股書給了答案。上半年營收 162.86 億美元，807 億美元淨損裡有 724 億是可轉債的帳面數字，營業虧損只剩 6.93 億，第二季已經轉正。能收錢的是賣模型這本帳；做藥那本帳，招股書沒拆營收，公司自己也說暫不做人體試驗。\n\n藥廠也沒閒著。諾和諾德 4 月簽 OpenAI、9 月再簽 Anthropic，用分散供應商回應資料疑慮。真正自己做藥的 Isomorphic Labs，首批臨床已從 2025 年底延到 2026 年底。\n\n2027 年底前，Anthropic 第一個自有藥物計畫會授權或共同開發給藥廠，而不是自己登錄人體試驗。它要的不是藥廠的病人，是談授權時的座位。\n\n台灣這邊，博弘雲端（6997）是 Anthropic 台灣經銷；台康生技（6589）正在擴充雙特異抗體 CDMO，接的是實驗室之後那一段。\n\n你覺得藥廠該不該把研發資料交給同時在做藥的 AI 公司？\n\n追蹤藥時事，每天拆解一筆全球醫藥大事背後的商業邏輯。","relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}